Beijing Strong Biotechnologies Inc (300406) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.86 Million ≈ $26.76 Million USD) by net assets (CN¥4.00 Billion ≈ $584.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Beijing Strong Biotechnologies Inc (300406) net asset quality to measure how much of total assets are equity-financed.

Beijing Strong Biotechnologies Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing Strong Biotechnologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Beijing Strong Biotechnologies Inc (300406) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Beijing Strong Biotechnologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Chenfeng Science and Technology Co Ltd Class A SHG:603685	0.026x
Jiangsu Zhongchao Cable Co Ltd SHE:002471	-0.010x
Redcare Pharmacy NV F:RDC	-0.039x
Aussie Broadband Ltd AU:ABB	0.052x
KPC Pharmaceuticals Inc SHG:600422	-0.002x
Beijing Sojo Electric Co Ltd SHE:300444	-0.097x
Shen Ma Industry Co Ltd SHG:600810	0.024x
TTK Prestige Limited NSE:TTKPRESTIG	0.018x

Annual Cash Flow Conversion Efficiency for Beijing Strong Biotechnologies Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Strong Biotechnologies Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 300406 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.13 Billion ≈ $604.76 Million	CN¥614.01 Million ≈ $89.85 Million	0.149x	-6.31%
2023-12-31	CN¥3.72 Billion ≈ $544.58 Million	CN¥590.15 Million ≈ $86.36 Million	0.159x	+30.84%
2022-12-31	CN¥3.27 Billion ≈ $478.32 Million	CN¥396.17 Million ≈ $57.97 Million	0.121x	+3.52%
2021-12-31	CN¥2.91 Billion ≈ $426.32 Million	CN¥341.10 Million ≈ $49.91 Million	0.117x	+225.72%
2020-12-31	CN¥3.42 Billion ≈ $500.96 Million	CN¥123.06 Million ≈ $18.01 Million	0.036x	-62.44%
2019-12-31	CN¥1.97 Billion ≈ $288.41 Million	CN¥188.60 Million ≈ $27.60 Million	0.096x	-36.41%
2018-12-31	CN¥1.70 Billion ≈ $249.09 Million	CN¥256.15 Million ≈ $37.48 Million	0.150x	+10.74%
2017-12-31	CN¥1.53 Billion ≈ $223.89 Million	CN¥207.91 Million ≈ $30.42 Million	0.136x	-22.45%
2016-12-31	CN¥1.39 Billion ≈ $203.11 Million	CN¥243.21 Million ≈ $35.59 Million	0.175x	+44.42%
2015-12-31	CN¥1.18 Billion ≈ $171.97 Million	CN¥142.59 Million ≈ $20.86 Million	0.121x	-23.69%
2014-12-31	CN¥987.03 Million ≈ $144.43 Million	CN¥156.94 Million ≈ $22.97 Million	0.159x	-48.55%
2013-12-31	CN¥476.31 Million ≈ $69.70 Million	CN¥147.19 Million ≈ $21.54 Million	0.309x	-5.02%
2012-12-31	CN¥385.67 Million ≈ $56.44 Million	CN¥125.49 Million ≈ $18.36 Million	0.325x	+104.63%
2011-12-31	CN¥288.66 Million ≈ $42.24 Million	CN¥45.90 Million ≈ $6.72 Million	0.159x	--

About Beijing Strong Biotechnologies Inc

SHE:300406 China Diagnostics & Research

Market Cap

$972.92 Million

CN¥6.65 Billion CNY

Market Cap Rank

#8903 Global

#2094 in China

Share Price

CN¥11.34

Change (1 day)

-1.99%

52-Week Range

CN¥10.82 - CN¥15.30

All Time High

CN¥24.76